Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | METAP1 | P53582 | 4/20 | 0.69 |
| ▸ | CYP19A1 | P11511 | 2/20 | 0.61 |
| ▸ | CYP24A1 | Q07973 | 6/20 | 0.49 |
| ▸ | CYP27A1 | Q02318 | 3/20 | 0.49 |
| ▸ | CYP26A1 | O43174 | 2/20 | 0.49 |
| ▸ | ACHE | P22303 | 1/20 | 0.46 |
| ▸ | THRA | P10827 | 1/20 | 0.45 |
| ▸ | THRB | P10828 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8596536 | 1.00 | METAP1 (0.69) | METAP1CYP19A1CYP24A1CYP27A1CYP26A1 | |
| SCHEMBL8874562 | 0.89 | METAP1 (0.69) | METAP1CYP19A1ACHE | |
| SCHEMBL8598724 | 0.89 | METAP1 (0.69) | METAP1CYP19A1ACHE | |
| SCHEMBL8599618 | 0.86 | METAP1 (0.64) | METAP1CYP19A1CYP24A1CYP27A1CYP26A1 | |
| SCHEMBL8599621 | 0.86 | METAP1 (0.64) | METAP1CYP19A1CYP24A1CYP27A1CYP26A1 | |
| SCHEMBL8874197 | 0.86 | METAP1 (0.64) | METAP1CYP19A1CYP24A1CYP27A1CYP26A1 | |
| SCHEMBL14306761 | 0.84 | METAP1 (0.72) | METAP1CYP19A1CYP24A1CYP27A1CYP26A1 | |
| SCHEMBL15617638 | 0.82 | METAP1 (0.70) | METAP1CYP19A1CYP24A1CYP27A1CYP26A1 | |
| SCHEMBL8596909 | 0.82 | METAP1 (0.65) | METAP1CYP19A1CYP24A1CYP27A1CYP26A1 | |
| SCHEMBL6272399 | 0.82 | METAP1 (0.65) | METAP1CYP19A1CYP24A1CYP27A1CYP26A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5646173-A | ANTISEROTONINE AGENTS; CENTRAL NERVOUS SYSTEM DISORDERS; ANTIDEPRESSANTS | HOFFMANN-LA ROCHE INC. (US) | 1997-07-08 | — | — | US | disclosed |